- Trials with a EudraCT protocol (16)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
16 result(s) found for: Potassium Deficiency.
Displaying page 1 of 1.
EudraCT Number: 2014-001518-25 | Sponsor Protocol Number: P-Monofer-IDA-02 | Start Date*: 2014-11-21 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A Phase III, Randomised, Double-blind, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) against Placebo in Subjects with Iron Deficiency Anaemia and who are Intolerant or Unrespon... | |||||||||||||
Medical condition: Subjects with iron deficiency anaemia (IDA) caused by different aetiologies such as abnormal uterine bleeding, gastrointestinal diseases (e.g. inflammatory bowel disease), cancer, preoperative anae... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001529-28 | Sponsor Protocol Number: P-Monofer-BD-02 | Start Date*: 2012-06-13 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A Randomized, Prospective, Double-Blind, Comparative Placebo-Controlled Study of Intravenous Iron Isomaltoside 1000 (Monofer®) administered by Infusions to Iron-Deficient Blood Donors | |||||||||||||
Medical condition: Female first-time bloddonors with iron deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003121-94 | Sponsor Protocol Number: P-Monofer-IBD-02 | Start Date*: 2011-12-14 | |||||||||||
Sponsor Name:Pharmacosmos A/S | |||||||||||||
Full Title: A Prospective, Non-controlled, Safety Study of Intravenous Iron Isomaltoside 1000 (Monofer®) administered by a High Dosing Regimen in Subjects with Inflammatory Bowel Disease (PROMISE) | |||||||||||||
Medical condition: Inflammatory Bowel Disease (IBD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003676-39 | Sponsor Protocol Number: 109147 | Start Date*: 2021-07-20 |
Sponsor Name: | ||
Full Title: Effects of sodium lactate infusion in patients with glucose transporter 1 deficiency syndrome (GLUT1DS) | ||
Medical condition: In glucose transporter 1 deficiency syndrome (GLUT1DS) cerebral glucose uptake from the systemic blood circulation is limited, because of deficient transport of glucose across the blood-brain barri... | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000500-29 | Sponsor Protocol Number: P150911 | Start Date*: 2016-06-03 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: A randomized Crossover TrIal to Compare recombinant human rhPTH(1-34) to the ASsociation alfacalcidol/hydrochlorothiazide in the treatment of Autosomal Dominant Hypocalcemia | |||||||||||||
Medical condition: Autosomal dominant hypocalcemia (ADH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005825-12 | Sponsor Protocol Number: PB-06-002 | Start Date*: 2009-06-04 | |||||||||||
Sponsor Name:Protalix Biotherapeutics | |||||||||||||
Full Title: Ensayo clinico de fase 3, multicéntrico, en abierto y con cambio de tratamiento para evaluar la seguridad y eficacia de Glucocerebrosidasa Humana Recombinante expresada en células vegetales (prGCD)... | |||||||||||||
Medical condition: Enfermedad de Gaucher Gaucher Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) GB (Completed) IT (Completed) DE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004139-35 | Sponsor Protocol Number: MNK14112096 | Start Date*: 2018-06-12 | |||||||||||
Sponsor Name:Mallinckrodt ARD Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Parallel Group, Double Blind, Multiple Dose, Placebo Controlled Study to Assess the Efficacy and Safety of MNK-1411 in Male Subjects 4 to 8 Years of Age With Duchenne Mus... | |||||||||||||
Medical condition: Duchenne Muscular Distrophy | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: ES (Prematurely Ended) BG (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000350-11 | Sponsor Protocol Number: 2032/MUL | Start Date*: 2014-05-28 | |||||||||||||||||||||
Sponsor Name:Multiplex Pharma Holdings LLC | |||||||||||||||||||||||
Full Title: An open label, randomized study to investigate the safety of weekly pentosan polysulfate injections in adult patients with Mucopolysaccharidosis Type I receiving enzyme replacement therapy. | |||||||||||||||||||||||
Medical condition: Mucopolysaccharidosis type I (alpha-L-Iduronidase deficiency) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004381-19 | Sponsor Protocol Number: NBI-74788-CAH2006 | Start Date*: 2021-06-07 | |||||||||||
Sponsor Name:Neurocrine Biosciences, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by O... | |||||||||||||
Medical condition: Classic Congenital Adrenal Hyperplasia (CAH) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Ongoing) DE (Completed) FR (Ongoing) PL (Ongoing) BE (Ongoing) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001264-22 | Sponsor Protocol Number: SILK/Eplerenone1 | Start Date*: 2012-11-08 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Region Skåne | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Eplerenone and spironolactone in male patients with ascites due to liver cirrhosis. A Swedish prospective randomized multicenter study of efficacy and endocrinologic side effects. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Ascites complicating liver cirrhosis in males | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Elderly | Gender: Male | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001472-22 | Sponsor Protocol Number: IMUNOR-201501 | Start Date*: 2017-03-14 | |||||||||||
Sponsor Name:ImunomedicA, a.s. | |||||||||||||
Full Title: A Prospective, Randomized, Double-Blind, Placebo-controlled, Multicenter, Phase III Study Assessing Efficacy and Safety of the IMUNOR® Therapy Versus Placebo in Patients with Recurrent Vulvovaginit... | |||||||||||||
Medical condition: Recurrent vulvovaginitis episodes | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SK (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004873-17 | Sponsor Protocol Number: NBI-74788-CAH3003 | Start Date*: 2020-10-15 | |||||||||||
Sponsor Name:Neurocrine Biosciences, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-... | |||||||||||||
Medical condition: Classic Congenital Adrenal Hyperplasia (CAH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Ongoing) CZ (Ongoing) FR (Ongoing) PT (Ongoing) BG (Ongoing) PL (Ongoing) GR (Ongoing) AT (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001679-27 | Sponsor Protocol Number: 123456 | Start Date*: 2016-02-01 | |||||||||||
Sponsor Name:CHU-ULg | |||||||||||||
Full Title: A PHASE I/II STUDY OF THE COMBINATION OF DEFERASIROX-VITAMIN D AND AZACITIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES (IPSS INT-2 and HIGH). | |||||||||||||
Medical condition: MYELODYSPLASTIC SYNDROMES | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001169-33 | Sponsor Protocol Number: SAFA-1-2012 | Start Date*: 2012-07-02 | ||||||||||||||||
Sponsor Name:Department of Medical Research | ||||||||||||||||||
Full Title: Effects of tolvaptan on renal sodium and water handling and circulation during inhibition of the nitric oxide system in healthy subjects | ||||||||||||||||||
Medical condition: SIADH (Syndrome of inappropriate ADH production) Overhydration Hyponatrimia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000452-16 | Sponsor Protocol Number: 156-03-244 | Start Date*: 2004-08-02 | |||||||||||
Sponsor Name:Otsuka Maryland Research Institute | |||||||||||||
Full Title: International, Multi-Centre, Study of One year, Open Label, Titrated Oral Tolvaptan Tablet Administration in Patients with Chronic Hyponatraemia: Extension to Studies 156-02-235 and 156-03-238 to a... | |||||||||||||
Medical condition: Ongoing hyponatraemia in euvolemic and hypervolemic states | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005186-18 | Sponsor Protocol Number: S187.3.004 | Start Date*: 2007-11-16 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals B.V. | |||||||||||||
Full Title: Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa – Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations | |||||||||||||
Medical condition: Treatment of levodopa-responsive Parkinson's subjects with severe motor fluctuations. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) PT (Completed) IT (Completed) CZ (Completed) ES (Completed) NL (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.